21268 ⎘
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient; Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
SUBLINGUAL OR BUCCAL DOSAGE FORMS COMPRISING ANTIOXIDANTS FOR TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS
#2SYRUP PREPARATION
#3Subcutaneous Formulations Of Anti-CD38 Antibodies And Their Uses
#4COMPOSITIONS AND METHODS FOR TREATING MULTIPLE SCLEROSIS
#5STABLE FORMULATION OF ARYLSULFONYLPROPENENITRILES
#6IONIZABLE CATIONIC LIPID FOR RNA DELIVERY
#7Edaravone Oral Solution Compositions
#8METHODS OF TREATING THYROID EYE DISEASE
#9AZAINDOLE ROCK INHIBITORS
#10STABLE FORMULATIONS OF A MULTIVALENT VHH BASED CYTOTOXIC T LYMPHOCYTE ASSOCIATED ANTIGEN 4 (CTLA4) BINDER BINDING TO HUMAN CTLA4 AND METHODS OF USE THEREOF
#11LIPOSOMAL FORMULATIONS OF BCL INHIBITORS
#12Liquid Pharmaceutical Formulations for an Anti-IL-1beta Antibody
#13Therapeutic and Topical Anti-Itch Composition
#14USE OF DIHYDROTANSHINONE I DERIVATIVE IN PREPARATION OF DRUG FOR TREATING CEREBRAL CAVERNOUS MALFORMATION
#15INJECTABLE EMULSION FORMULATIONS OF CLEVIDIPINE
#16DOPA DECARBOXYLASE INHIBITOR COMPOSITIONS
#17Antibody Compositions and Methods of Use Thereof
#18CANCER TREATMENT BY INDUCTION OF TUMOR AND STEM CELL DIFFERENTIATION
#19ION PAIR LIQUID CRYSTAL FORMULATIONS FOR LONG-ACTING INJECTABLES OF POORLY SOLUBLE DRUGS
#20HALIDE-FREE AMMONIUM SILANES
#21AQUEOUS PHARMACEUTICAL FORMULATION OF HYDROCORTISONE SODIUM PHOSPHATE AND MONOTHIOGLYCEROL
#22PHARMACEUTICAL TOPICAL FORMULATIONS OF LIDOCAINE AND KETAMINE
#23COMPOSITIONS FOR TOPICAL AND TRANSDERMAL DRUG DELIVERY
#24COMPOSITIONS AND METHODS FOR TREATMENT OF TRAUMATIC BRAIN INJURY (TBI), FOR EXAMPLE, MILD TRAUMATIC BRAIN INJURY (mTBI)
#25PROTEIN NANOSPHERES AND METHOD TO TREAT DYSFUNCTION FROM CHEMOTHERAPY AND IMMUNOSUPPRESSIVE THERAPY
#26FORMULATIONS AND DOSAGE AMOUNTS FOR ADMINISTERING AN ANTI-DPP3 ANTIBODY OR FRAGMENT THEREOF TO HUMANS
#27Prodrugs of Cannbidiol [CBD]-Type Phytocannabinoids and a Process for Preparation Thereof
#28STABLE LEVOTHYROXINE COMPOSITIONS IN APROTIC POLAR SOLVENTS
#29EPINEPHRINE FORMULATIONS
#30FORMULATIONS FOR ANTI-INSULIN RECEPTOR ANTIBODY AND USES THEREOF
#31COMPOSITIONS AND METHODS FOR INDUCING IMMUNE RESPONSES
#32STABLE PHARMACEUTICAL COMPOSITIONS OF EDARAVONE
#33Pharmaceutical Formulation and Dosing Regimen for the Treatment of Amyotrophic Lateral Sclerosis
#34ENHANCED PATCH PUMP AND COMBINATION CONTROL SYSTEMS WITH ALARM ANNUNCIATION AND PRIORITIZATION AND BIHORMONAL VERSIONS WITH GLUCAGON
#35ALLOGENEIC MESENCHYMAL STEM CELLS FOR THE TREATMENT OF RETINAL DISORDERS ASSOCIATED WITH THE PRESENCE OF DRUSEN
#36COMPOUNDS AND COMBINATIONS THEREOF FOR TREATING NEUROLOGICAL AND PSYCHIATRIC CONDITIONS
#37TOPICAL ANALGESIC FOR RAPID RELIEF OF JOINT AND MUSCLE PAIN WITHOUT NUMBING AGENTS
#38ISOTHIOCYANATE FUNCTIONAL SURFACTANTS, FORMULATIONS INCORPORATING THE SAME, AND ASSOCIATED METHODS OF USE
#39FACE AND BODY OIL COMPOSITION
#40PHARMACEUTICAL COMPOSITIONS OF SPIRONOLACTONE FOR DEEP DERMAL DRUG DELIVERY
#41KAEMPFEROL BIOMIMETIC NANO-MATERIAL, METHOD FOR PREPARING SAME AND USE THEREOF
#42METHODS OF ADMINISTERING NATURAL KILLER CELLS COMPRISING AN ANTI-HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR 2 (HER2) CHIMERIC ANTIGEN RECEPTOR (CAR)
#43COMPOSITIONS AND METHODS FOR ENHANCING THE EFFICACY OF DICARBOXYLIC ACID ESTERS, AND USES THEREOF
#44REPARIXIN LIQUID SUSPENSIONS
#45INTRANASAL ADMINISTRATION OF BDNF FOR THE TREATMENT OF SENSORINEURAL HEARING LOSS
#46STABLE CYCLODEXTRIN FREE CARFILZOMIB FORMULATION
#47COMPOSITIONS FOR RETARDING THE DECOMPOSITION OF MELATONIN IN SOLUTION
#48VISCOSITY REDUCING EXCIPIENTS AND COMBINATIONS THEREOF FOR HIGHLY CONCENTRATED NUCLEIC ACID COMPOSITIONS
#49ANTI-TIGIT ANTIBODY FORMULATION
#50Compositions Comprising an Antimicrobial Boosting Agent
#51PHARMACEUTICAL COMPOSITIONS OF PROGRAMMED DEATH RECEPTOR 1 (PD-1) ANTIBODIES AND PH20 VARIANTS OR FRAGMENTS THEREOF
#52PHARMACEUTICAL COMPOSITIONS OF PROGRAMMED DEATH RECEPTOR 1 (PD-1) ANTIBODIES AND rHuPH20 OR VARIANTS OR FRAGMENTS THEREOF
#53ENHANCED SALICYLIC ACID AND DRUG DELIVERY FOR AQUEOUS TOPICAL APPLICATIONS
#54EPINEPHRINE FORMULATIONS
#55HIGH SURFACE-AREA LYOPHILIZED COMPOSITIONS COMPRISING ARSENIC FOR ORAL ADMINISTRATION IN PATIENTS
#56LOCAL ANESTHETIC SOLUTION FOR DENTAL AND/OR CONTRAST MEDIA USE
#57STARCH-BASED HYDROGEL FOR ADMINISTRATION OF THERAPEUTIC ANTICANCER AGENTS
#58PHARMACEUTICAL FORMULATIONS OF FCRN INHIBITORS SUITABLE FOR SUBCUTANEOUS ADMINISTRATION
#59COMPOSITIONS AND METHODS FOR DEGENERATIVE DISC REGENERATION
#60USE OF INHIBITORS OF BRUTONS TYROSINE KINASE (BTK)
#61Subcutaneous anti-HER2 Antibody Formulations and Uses Thereof
#62NICLOSAMIDE FORMULATIONS AND METHODS OF USE
#63Sublingual Epinephrine Compositions Including pH-Modifying Excipients And Penetration Enhancers And Methods for Use Thereof
#64FORMULATIONS OF BENDAMUSTINE
#65Subcutaneous Formulations Of Anti-CD38 Antibodies And Their Uses
#66PH STABILIZED OPHTHALMIC COMPOSITIONS
#67PROSTAGLANDIN ANALOGS AND METHODS FOR SUSTAINED GLAUCOMA MANAGEMENT
#68TREATMENTS FOR DISEASES AND DISORDERS THAT INVOLVE OXIDATIVE STRESS
#69METHODS OF MANUFACTURING PEPTIDE-BASED VACCINES
#70Methods for Treating Metastatic Pancreatic Cancer Using Combination Therapies Comprising Liposomal Irinotecan and Oxaliplatin
#71TOPICAL PHARMACEUTICAL COMPOSITIONS AND USES THEREOF
#72VISCOSITY-REDUCING EXCIPIENT COMPOSITION AND LOW-VISCOSITY HIGHLY CONCENTRATED PROTEIN FORMULATION CONTAINING SAME
#73PHARMACEUTICAL COMPOSITION
#74TRANSDERMAL PACKAGING MEMBRANES
#75NON-TOXIC PHOTOSENSITIZER COMPOSITION AND TWO-COMPONENT TYPE PHOTOSENSITIZER COMPOSITION COMPRISING THE SAME
#76PHOTODYNAMIC THERAPY COMPOSITIONS AND METHODS OF USE THEREOF
#77CELL DELIVERY VEHICLE AND METHODS OF USING THE SAME
#78TOPICAL FORMULATIONS OF CYCLOOXYGENASE INHIBITORS AND THEIR USE
#79ANHYDROUS SODIUM THIOSULFATE AND FORMULATIONS THEREOF
#80STABLE CYCLODEXTRIN FREE CARFILZOMIB FORMULATION
#81COMBINATION OF ANTIBODY-DRUG CONJUGATE AND IMMUNE CHECKPOINT INHIBITOR
#82FUSION POLYPEPTIDES AND FORMULATIONS THEREOF
#83COMPOSITIONS TARGETING BCMA AND METHODS OF USE THEREOF
#84PHARMACEUTICAL COMPOSITION COMPRISING A GLP-1-AGONIST AND METHIONINE
#85LIQUID FORMULATION OF IL-22R ANTIBODY
#86ANTIBODY COMPOSITIONS AND METHODS OF USE THEREOF
#87TRANSDERMAL ANTICOAGULANT COMPOSITIONS
#88HIGHLY WATER-SOLUBLE SALTS OF A SHORT ACTING PHENYLALKYLAMINE CALCIUM CHANNEL BLOCKER AND USES THEREOF
#89Formulations of DR5 Binding Polypeptides
#90TOPICAL FORMULATION COMPRISING OMEGA-3 FATTY ACIDS, MELATONIN AND VITAMIN D
#91PHARMACEUTICAL COMPOSITIONS CONTAINING ANTI-HER2 ANTIBODY FOR SUBCUTANEOUS ADMINISTRATION
#92PROSTACYCLIN ANALOGUE FORMULATIONS
#93HUMAN UMBILICAL CORD BLOOD FOR USE IN ALLEVIATING FATIGUE
#94METHOD OF SYNTHESIS OF AN IONIZABLE CATIONIC LIPID
#95FULVESTRANT FORMULATIONS
#96Topical Compositions and Methods for Treatment of Diabetic Neuropathies
#97FORMULATIONS OF PHOSPHORAMIDATE DERIVATIVES OF NUCLEOSIDE DRUGS
#98COMPOSITIONS AND METHODS FOR DELIVERY OF RIBOFLAVIN
#99ORAL GLIPTIN COMPOSITIONS AND METHOD FOR PREPARATION THEREOF
#100COMPOSITIONS, METHODS AND SYSTEMS FOR THE TREATMENT OF CUTANEOUS DISORDERS
#101LONG-ACTING INJECTABLE PHARMACEUTICAL COMPOSITIONS COMPRISING BIODEGRADABLE POLYMERS FOR DRUG DELIVERY
#102FORMULATIONS OF BENDAMUSTINE
#103Multifunctional Nanoparticles For Prevention and Treatment of Atherosclerosis
#104SOLID COMPOSITIONS COMPRISING A GLUCOKINASE ACTIVATOR AND METHODS OF MAKING AND USING THE SAME
#105Purified pentagalloyl glucose and devices for delivery
#106THIOSTREPTON COMPOSITIONS AND PREPARATION THEREOF
#107STABLE FORMULATIONS FOR TNF-alpha ANTIBODIES AND USES THEREOF
#108COMPOSITIONS AND METHODS FOR ELICITING AN IMMUNE RESPONSE PROTECTIVE AGAINST LYME DISEASE
#109METHODS FOR TREATING CONGENITAL EPIDERMAL HYPERPLASIA AND COMPOSITIONS FOR SAME
#110OPHTHALMIC COMPOSITION INHIBITING OCCURRENCE OF N-OXOPYRIDINE COMPOUND FOR PREVENTING OR TREATING EYE DISEASE
#111R-KETAMINE LIQUID PREPARATION AND USE THEREOF
#112VODOBATINIB FOR REDUCING PROGRESSION OF PARKINSON'S DISEASE
#113COMPOSITIONS AND METHODS FOR TREATING EPILEPSY, SEIZURES AND OTHER CONDITIONS
#114Subcutaneous Formulations Of Anti-CD38 Antibodies And Their Uses
#115OPTHALMIC FORMULATIONS AND USES THEREOF
#116STABLE PHARMACEUTICAL COMPOSITIONS OF EDARAVONE
#117DRUG DELIVERY FORMULATIONS
#118PLATFORM NANOPARTICLE TECHNOLOGY FOR SUSTAINED DELIVERY OF HYDROPHOBIC DRUGS
#119HIGH CONCENTRATION ANTIBODY-CONTAINING LIQUID FORMULATION
#120METHODS FOR TREATING HAIR LOSS AND NAIL BRITTLENESS, FRAGILITY, OR PITTING
#121PHARMACEUTICAL COMPOSITION AND ADMINISTRATIONS THEREOF
#122EXOSOME SYSTEMS, PRODUCTS AND METHODS
#123INSULIN PREPARATIONS CONTAINING METHIONINE
#124AZAINDOLE ROCK INHIBITORS
#125COMPOSITIONS AND METHODS FOR TREATING AND/OR PREVENTING A VIRAL INFECTION
#126MATERIALS AND METHODS FOR IMPROVING GASTROINTESTINAL FUNCTION
#127METHOD FOR RELIEVING CANCER PAIN
#128NOVEL COMPOSITION
#129BIOLOGICALLY ACTIVE GANODERMA LUCIDUM COMPOUNDS AND SYNTHESIS OF ANTICANCER DERIVATIVES; ERGOSTEROL PEROXIDE PROBES FOR CELLULAR LOCALIZATION
#130TADALAFIL ORAL SUSPENSION
#131INJECTABLE FORMULATION
#132SARS-CoV-2 VACCINE COMPOSITIONS
#133NOVEL PHARMACEUTICAL FORMULATION
#134STABLE PHARMACEUTICAL COMPOSITIONS OF EDARAVONE
#135Production of Biosimilar Ustekinumab In CHO Cells
#136ANTI-CD3 ANTIBODY FORMULATIONS
#137NEOANTIGENS AND USES THEREOF
#138BROAD SPECTRUM ANTISEPTIC NANO EMULSION BASED ON A COMBINATION OF IONIC LIQUID AND COPPER NANOCLUSTERS
#139OROMUCOSAL THERAPEUTIC SYSTEM CONTAINING AN ADHESIVE LAYER
#140METHODS AND COMPOSITIONS FOR TREATMENT OF AGE-RELATED CATARACTS
#141PREPARATION OF LOW MOLECULAR WEIGHT POLYLACTIC ACID AND THE USE THEREOF
#142THERAPEUTIC PHARMACEUTICAL COMPOSITIONS
#143COMPOSITIONS AND METHODS FOR TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS (ALS) AND OTHER NEURODEGENERATIVE DISEASES, AND ASSOCIATED METHODS FOR PREPARING SAID COMPOSITIONS
#144A PREMIXED ROOM TEMPERATURE STABLE COMPOSITION OF FAMOTIDINE FOR INTRAVENOUS BOLUS INJECTION AND METHOD THEREOF
#145ENRICHED AND STABLE RADIOLIGAND THERAPY FORMULATIONS AND PHARMACEUTICAL COMPOSITIONS COMPRISING SAME
#146Antibody Compositions and Methods of Use Thereof
#147Orally Available Albenatide
#148DERMAL AND TRANSDERMAL ADMINISTRATION OF TREPROSTINIL AND SALTS THEREOF
#149HIGHLY CONCENTRATED PHARMACEUTICAL FORMULATIONS
#150High Concentration Bispecific Antibody Formulations
#151LONG-LASTING ANTIMICROBIAL COMPOSITIONS CONTAINING CATIONIC ACTIVE AGENTS AND ANIONIC EXCIPIENTS AND USES
#152EXOSOME SYSTEMS, PRODUCTS AND METHODS
#153LIQUID FORMULATIONS OF GLUCAGON ANALOGUES
#154FORMULATIONS OF BENDAMUSTINE
#155PHARMACEUTICAL COMPOSITION COMPRISING NICLOSAMIDE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF AND PREPARATION METHOD THEREFOR
#156FORMULATIONS OF BENDAMUSTINE
#157CORONAVIRUS VACCINE COMPOSITIONS AND METHODS
#158ROTIGOTINE-CONTAINING ADHESIVE PATCH
#159AGENTS, COMPOSITIONS AND METHODS FOR ENHANCED DELIVERY OF NUCLEIC ACIDS TO THE CELLS WITHIN THE RESPIRATORY SYSTEM
#160TOPICAL FORMULATIONS COMPRISING TOFACITINIB
#161MULTICOMPONENT DEGRADABLE CATIONIC POLYMERS
#162ULTRAFLEXIBLE LIPOSOMES IN GEL FORMULATION
#163CNP PRODRUGS WITH LARGE CARRIER MOIETIES
#164HALIDE-FREE AMMONIUM SILANES
#165Subcutaneous anti-HER2 Antibody Formulations and Uses Thereof
#166METHOD AND COMPOSITION FOR TREATING PARASITES IN AN ANIMAL
#167Azaindole rock inhibitors
#168NIR BIOSAFE QR CODES WITH BIOINKJET PRINTING AND TAGGING
#169ORAL DISPERSIBLE FILM OF SEMAGLUTIDE AND PREPARATION METHOD THEREOF
#170COMPOSITION COMPRISING TETRACYCLIC COMPOUND
#171CONTINUOUS ADMINISTRATION OF L-DOPA, DOPA DECARBOXYLASE INHIBITORS, CATECHOL-O-METHYL TRANSFERASE INHIBITORS AND COMPOSITIONS FOR SAME
#172SUBLINGUAL FORMULATION OF RILUZOLE
#173Liquid supramolecular self-recognition system of low-pH azelaic acid, and preparation method therefor and application thereof
#174ANTIBIOTIC PHARMACEUTICAL COMPOSITION CAPABLE OF SUBCUTANEOUS ADMINISTRATION
#175Pharmaceutical Formulation
#176Azaindole rock inhibitors
#177Subcutaneous anti-HER2 Antibody Formulations and Uses Thereof
#178METHOD OF TREATING PROGRESSIVE HEART FAILURE IN SUBJECTS AT HIGH RISK OF POOR OUTCOMES
#179STABLE FORMULATIONS OF SHR0302
#180HIGHLY WATER-SOLUBLE SALTS OF A SHORT ACTING PHENYLALKYLAMINE CALCIUM CHANNEL BLOCKER AND USES THEREOF
#181Topical anesthetic agent-clay composite compositions
#182TRANSDERMAL INSULIN FORMULATIONS AND METHODS OF USE THEREOF
#183TRACE ELEMENT COMPOSITIONS, METHODS OF MAKING AND USE
#184TRACE ELEMENT COMPOSITIONS, METHODS OF MAKING AND USE
#185STABLE PHARMACEUTICAL COMPOSITIONS OF APIXABAN
#186MURICHOLIC ACIDS AND DERIVATIVES FOR CHOLESTASIS TREATMENT
#187SOLID FORMS OF MESEMBRINE AND THERAPEUTIC USES THEREOF
#188DOPA DECARBOXYLASE INHIBITOR COMPOSITIONS
#189L-N-isobutyryl cysteine (L-NIBC)-bound gold cluster Au18(L-NIBC)14, compositions and applications thereof
#190Mushroom Spore, Cannabinoid, and Specified Compositions
#191COMPOUNDS AND COMBINATIONS THEREOF FOR TREATING NEUROLOGICAL AND PSYCHIATRIC CONDITIONS
#192AQUEOUS FORMULATION COMPRISING PARACETAMOL AND IBUPROFEN
#193PATCH
#194STABILISED LIQUID VACCINES OF LIVE VIRUSES
#195SYSTEMS, COMPOSITIONS AND METHODS FOR TREATING DIABETES
#196STABLE LEVOTHYROXINE COMPOSITIONS IN APROTIC POLAR SOLVENTS
#197NOVEL IONIZABLE LIPIDS AND LIPID NANOPARTICLES AND METHODS OF USING THE SAME
#198Transdermal Delivery Systems and Methods for Inhibiting, Stopping, Blocking, or Modulating Glutaminolysis, Glutamine, and Other Glutaminolysis Catalyzing Enzymes Across Multiple Metabolic Pathways in Human Beings and Animals
#199ZIPRASIDONE FORMULATIONS
#200NICLOSAMIDE FORMULATIONS AND METHODS OF USE
#201INJECTABLE BUPRENORPHINE FORMULATION
#202STABILIZED RADIOPHARMACEUTICAL COMPOSITION
#203Novel Polymeric hGH Prodrugs
#204STABLE LIQUID COMPOSITIONS OF GLUCAGON
#205REVITALIZING EYE DROPS
#206Methods of Making and Using Polyphenols Complexed With a Protein, Peptide, Amino Acid, Polysaccharide, Disaccharide, or Monosaccharide
#207BOTULINUM NEUROTOXIN COMPOSITION
#208PREPARATION OF A THERAPEUTIC COMPOSITION FOR TREATING AUTOIMMUNE DISEASES
#209NANOSUSPENSION CONTAINING PROGERININ, AND PREPARATION METHOD THEREFOR
#210Hydrocortisone Acetate Suppository Formulation For Treatment Of Disease
#211TOPICAL ANALGESICS
#212PH STABILIZED OPHTHALMIC COMPOSITIONS
#213PH STABILIZED OPHTHALMIC DEXAMETHASONE COMPOSITIONS
#214TREATMENT OF DIABETIC RETINOPATHY WITH OPHTHALMIC COMPOSITIONS
#215TREATMENT OF OCULAR INFLAMMATION WITH OPHTHALMIC COMPOSITIONS
#216STABILIZED OPHTHALMIC DEXAMETHASONE COMPOSITIONS
#217TREATMENT OF OCULAR INFLAMMATION FOLLOWING OCULAR SURGERY
#218DONEPEZIL ORAL FILMS
#219PATCH
#220PHARMACEUTICAL COMPOSITION
#221METHODS FOR PREPARING AND ADMINISTERING CRYOPRESERVED PLATELETS AND PLATELET DERIVATIVES LOADED WITH ANTI-CANCER DRUGS
#222NOVEL LIPIDS AND COMPOSITIONS FOR THE DELIVERY OF THERAPEUTICS
#223TREATMENT OF CANCER WITH NK CELLS AND MULTISPECIFIC ENGAGERS
#224Formulations for VEGF Receptor Fusion Proteins
#225Improved Nasal Administration of Parkinson's Therapeutics
#226CONTINUOUS DELIVERY PREPARATION CAPABLE OF BEING STABLY RELEASED AND PREPARATION METHOD THEREFOR
#227LIPOPHILIC SIRNA CONJUGATES FOR THE TREATMENT OF CENTRAL NERVOUS SYSTEM DISEASES
#228PHARMACEUTICAL HYDROCORTISONE SOLUTION FOR INJECTION DEVICE
#229SULFUR-CONTAINING IONIZABLE LIPIDS FOR THE DELIVERY OF NUCLEIC ACIDS AND OTHER THERAPEUTIC AGENTS
#230GROUP B ADENOVIRUS-CONTAINING FORMULATION
#231Topical Compositions and Methods for Hair Growth
#232Immediate release pharmaceutical formulation of 4-[3-(4-cyclopropanecarbonyl-piperazine-1-carbonyl)-4-fluoro-benzyl]-2H-phthalazin-1-one
#233HIGH CONCENTRATION ANTIBODY-CONTAINING LIQUID FORMULATION
#234LIPOCATIONIC DENDRIMERS AND USES THEREOF
#235PHARMACEUTICAL COMPOSITION COMPRISING A GLP-1 AGONIST, AN INSULIN AND METHIONINE
#236LAURETH-4 CONTAINING TOPICAL FORMULATIONS
#237FORMULATIONS FOR TRANSDERMAL ADMINISTRATION OF ACTIVE AGENTS
#238FORMULATIONS OF ANTI-INFLAMMATORY AGENTS COMPRISING MSM WITH ENHANCED SOLUBILITY IN WATER
#239COMPOSITIONS COMPRISING STREPTOCOCCUS PNEUMONIAE POLYSACCHARIDE-PROTEIN CONJUGATES AND METHODS OF USE THEREOF
#240COMPOSITIONS AND METHODS FOR DEEP DERMAL DRUG DELIVERY
#241IMMEDIATE RELEASE PHARMACEUTICAL FORMULATION OF 4-[3-(4-CYCLOPROPANECARBONYL-PIPERAZINE-1-CARBONYL)-4-FLUORO-BENZYL]-2H-PHTHALAZIN-1-ONE
#242HIGH CONCENTRATION ANTIBODY-CONTAINING LIQUID FORMULATION
#243Use of C-Type Natriuretic Peptide Variants to Treat Skeletal Dysplasia
#244NOVEL THERAPY
#245COMPOSITIONS AND METHODS FOR TREATING PEDICULOSIS
#246BIOAVAILABLE COMPOSITIONS INCLUDING NANOPARTICULATED INGREDIENTS FOR REDUCING OXIDATIVE STRESS
#247DISCOVERY OF NOVEL TRPV1 CHANNEL BLOCKERS BY HIGH-THROUGHPUT SCREENING OF MARINE NATURAL PRODUCTS
#248Methods for Treating Metastatic Pancreatic Cancer Using Combination Therapies Comprising Liposomal Irinotecan and Oxaliplatin
#249Anhydrous Sodium Thiosulfate and Formulations Thereof
#250Compositions targeting BCMA and methods of use thereof
#251PHARMACEUTICAL FORMULATION AND A PROCESS FOR ITS PREPARATION
#252METHODS FOR PRODUCING STABLE THERAPEUTIC FORMULATIONS IN APROTIC POLAR SOLVENTS
#253TOPICAL LIQUID COMPOSITIONS FOR TREATING HAIR LOSS
#254NANOMATERIALS COMPRISING DISULFIDES
#255PENETRATING TOPICAL PAIN RELIEF COMPOSITIONS AND METHODS OF USE
#256COMPOUNDED COMPOSITIONS AND METHODS FOR TREATING PAIN
#257STABLE PHARMACEUTICAL COMPOSITIONS OF APOMORPHINE
#258Olanzapine compositions and methods of use
#259TOFACITINIB-CONTAINING ANHYDROUS ELASTOMER-BASED GEL FORMULATIONS
#260HIGH CONCENTRATION ANTIBODY-CONTAINING LIQUID FORMULATION
#261STABLE THERAPEUTIC COMPOSITIONS IN APROTIC POLAR SOLVENTS AND METHODS OF MANUFACTURING THE SAME
#262CNP PRODRUGS WITH LARGE CARRIER MOIETIES
#263Trace element compositions, methods of making and use
#264STABLE FORMULATIONS OF INDOCYANINE GREEN
#265Trace element compositions, methods of making and use
#266COMPOSITIONS AND METHODS FOR DIAGNOSIS AND TREATMENT OF AUTOIMMUNE DISEASES
#267SHELF-STABLE FORMULATIONS OF BENZOYL PEROXIDE AND METHODS OF PRODUCING SAME
#268FIDGETIN-LIKE 2 AS A TARGET TO ENHANCE WOUND HEALING
#269Safe and Effective Method of Treating Ulcerative Colitis with Anti-IL12/IL23 Antibody
#270FORMULATIONS OF BENDAMUSTINE
#271Formulations of bendamustine
#272DEVELOPMENT OF AN INNOVATIVE INHALATION FORMULATION OF NAFAMOSTAT MESYLATE FOR THE MANAGEMENT OF COVID-19
#273Compositions Comprising Antioxidant, Fluid Dispensers, and Methods Involving the Same
#274FORMULATION FOR ANTI-FCRN ANTIBODY
#275INJECTABLE, BIODEGRADABLE AND REMOVABLE POLYMER BASED DRUG SUSPENSION FOR ULTRA-LONG-ACTING DRUG DELIVERY
#276Liquid Protein Formulations Containing Ionic Liquids
#277COMPOSITION FOR WOUND RELIEF AND INHIBITING A PHD PROTEIN AND METHODS OF TREATMENT
#278Oral gliptin compositions and method for preparation thereof
#279STABLE PHARMACEUTICAL COMPOSITIONS OF EDARAVONE
#280ISOTHIOCYANATE FUNCTIONAL SURFACTANTS, FORMULATIONS INCORPORATING THE SAME, AND ASSOCIATED METHODS OF USE
#281INJECTABLE FORMULATION
#282Methods and compositions for treating cancer
#283Compositions and methods for treating epilepsy, seizures and other conditions
#284HIGHLY WATER-SOLUBLE SALTS OF A SHORT ACTING PHENYLALKYLAMINE CALCIUM CHANNEL BLOCKER AND USES THEREOF
#285Preparation
#286COMPOSITIONS AND METHODS FOR INJECTING PARTICLE SUSPENSIONS
#287NADES FORMULATIONS COMPRISING PHARMACEUTICALS
#288High Surface-Area Lyophilized Compositions Comprising Arsenic For Oral Administration In Patients
#289SUBCUTANEOUS HER2 ANTIBODY FORMULATIONS
#290POLYNUCLEOTIDE COMPOSITIONS, RELATED FORMULATIONS, AND METHODS OF USE THEREOF
#291Sulfur-containing ionizable lipids for the delivery of nucleic acids and other therapeutic agents
#292Azaindole rock inhibitors
#293LIPID NANOMATERIALS AND USES THEREOF
#294CANINE TOPICAL FORMULATIONS AND METHODS THEREOF
#295Azaindole rock inhibitors
#296STABLE SUSTAINED RELEASE THERAPEUTIC COMPOSITIONS IN APROTIC POLAR SOLVENTS AND METHODS OF MANUFACTURING THE SAME
#297AQUEOUS PHARMACEUTICAL FORMULATION OF HYDROCORTISONE SODIUM PHOSPHATE AND MONOTHIOGLYCEROL
#298OLANZAPINE COMPOSITIONS AND METHODS OF USE
#299FAST DISSOLVING ORAL FILM PREPARATION COMPRISING RIVAROXABAN
#300NON-LETHAL DEFENSIVE FLUID COMPOSITION AND PRESSURIZED DELIVERY SYSTEM